ArticleClinical lymphoma, myeloma & leukemia2023

Bendamustine/Rituximab Plus Cytarabine/Rituximab, With or Without Acalabrutinib, for the Initial Treatment of Transplant-Eligible Mantle Cell Lymphoma Patients: Pooled Data From Two Pilot Studies.

Dilan A Patel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.